C. Hatleberg

发表

Gender differences in the use of cardiovascular interventions in HIV‐positive persons; the D:A:D Study

A. Mocroft, A. d’Arminio Monforte, C. Sabin, 2018, Journal of the International AIDS Society.

Abacavir use and risk of recurrent myocardial infarction

A. Mocroft, O. Kirk, A. d’Arminio Monforte, 2018, AIDS.

Abacavir use and risk of recurrent myocardial infarction: the D: A: D study

A. Mocroft, O. Kirk, R. Weber, 2018 .

Improvements over time in short-term mortality following myocardial infarction in HIV-positive individuals

A. Mocroft, R. Weber, C. Sabin, 2016, AIDS.

Cessation of Cigarette Smoking and the Impact on Cancer Incidence in Human Immunodeficiency Virus–infected Persons: The Data Collection on Adverse Events of Anti-HIV Drugs Study

A. Mocroft, A. d’Arminio Monforte, R. Weber, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Effect of changes in body mass index on the risk of cardiovascular disease and diabetes mellitus in HIV-positive individuals: results from the D: A: D study\.

A. Mocroft, A. d’Arminio Monforte, R. Weber, 2020, Journal of acquired immune deficiency syndromes.

Body Mass Index and the Risk of Serious Non-AIDS Events and All-Cause Mortality in Treated HIV-Positive Individuals: D A D Cohort Analysis

A. Mocroft, R. Weber, C. Sabin, 2018, Journal of acquired immune deficiency syndromes.

Risk for Non–AIDS-Defining and AIDS-Defining Cancer of Early Versus Delayed Initiation of Antiretroviral Therapy

A. Mocroft, O. Kirk, A. d’Arminio Monforte, 2021, Annals of Internal Medicine.

Associations between serum albumin and serious non-AIDS events among people living with HIV

A. Mocroft, A. d’Arminio Monforte, R. Weber, 2018, AIDS.

A review of paediatric tuberculosis in Denmark: 10-year trend, 2000–2009

J. N. Rasmussen, V. Thomsen, S. Bjerrum, 2013, European Respiratory Journal.

Role of pre-stroke immunity in ischemic stroke mechanism among patients with HIV

M. Yin, J. Gutierrez, C. Hatleberg, 2018, AIDS care.

Cardiovascular disease and use of contemporary protease inhibitors: the D:A:D international prospective multicohort study.

Peter Reiss, Ole Kirk, Eric Fontas, 2018, The lancet. HIV.

Predictors of Ischemic and Hemorrhagic Strokes Among People Living With HIV: The D:A:D International Prospective Multicohort Study☆

A. Mocroft, O. Kirk, A. d’Arminio Monforte, 2019, EClinicalMedicine.

Title: A review of paediatric tuberculosis in Denmark: ten year trend, 2000 - 2009 Authors:

J. N. Rasmussen, V. Thomsen, S. Bjerrum, 2013 .

Association between exposure to antiretroviral drugs and the incidence of hypertension in HIV‐positive persons: the Data Collection on Adverse Events of Anti‐HIV Drugs (D:A:D) study

O. Kirk, A. d’Arminio Monforte, C. Sabin, 2018, HIV medicine.

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.

Cardiovascular disease (CVD) and chronic kidney disease (CKD) event rates in HIV-positive persons at high predicted CVD and CKD risk: A prospective analysis of the D:A:D observational study

A. Mocroft, R. Weber, C. Sabin, 2017, PLoS medicine.

Differences in Virological and Immunological Risk Factors for Non-Hodgkin and Hodgkin Lymphoma

A. Mocroft, C. Sabin, M. Battegay, 2017, Journal of the National Cancer Institute.

International Congress of Drug Therapy in HIV Infection 2‐6 November 2014, Glasgow, UK

Samit R. Joshi, Charlene A Flash, Thomas Lengauer, 2014 .

Are we successfully managing cardiovascular disease in people living with HIV?

J. Lundgren, C. Hatleberg, L. Ryom, 2017, Current opinion in HIV and AIDS.

Incidence of hypertension in people with HIV who are treated with integrase inhibitors versus other antiretroviral regimens in the RESPOND cohort consortium

A. Mocroft, J. Gallant, F. Wit, 2022, HIV medicine.

Cardiovascular risks associated with protease inhibitors for the treatment of HIV

C. Sabin, C. Hatleberg, L. Ryom, 2021, Expert opinion on drug safety.

Cost‐effectiveness of statins for primary prevention of atherosclerotic cardiovascular disease among people living with HIV in the United States

A. Mocroft, A. d’Arminio Monforte, R. Weber, 2021, Journal of the International AIDS Society.

Use of contemporary protease inhibitors and risk of incident chronic kidney disease in HIV-positive persons; the D:A:D Study.

A. Mocroft, O. Kirk, A. d’Arminio Monforte, 2019, The Journal of infectious diseases.

Serious clinical events in HIV-positive persons with chronic kidney disease (CKD).

A. Mocroft, O. Kirk, R. Weber, 2019, AIDS.

Renal Impairment and Cardiovascular Disease in HIV-Positive Individuals: The D:A:D Study.

A. Mocroft, O. Kirk, C. Sabin, 2016, The Journal of infectious diseases.

Trends in Cancer Incidence in Different Antiretroviral Treatment-Eras amongst People with HIV

A. Mocroft, A. d’Arminio Monforte, C. Sabin, 2023, Cancers.

Gender differences in the use of cardiovascular interventions in HIV‐positive persons; the D:A:D Study

A. Mocroft, A. d’Arminio Monforte, C. Sabin, 2018, Journal of the International AIDS Society.

Renal Impairment and Cardiovascular Disease in HIV-Positive Individuals: The D:A:D Study.

A. Mocroft, O. Kirk, C. Sabin, 2016, The Journal of infectious diseases.